Genix Pharmaceuticals Ratios and Metrics

Market cap in millions CAD. Fiscal year is November - October.

Millions CAD. Fiscal year is Nov - Oct.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Feb '26 Feb 27, 2026	Oct '25 Oct 31, 2025	Oct '24 Oct 31, 2024	Oct '23 Oct 31, 2023	Oct '22 Oct 31, 2022	Oct '21 Oct 31, 2021
Market Capitalization	1	2	3	2	4	9
Market Cap Growth	-87.84%	-37.97%	25.00%	-38.46%	-56.67%	-9.37%
Enterprise Value	2	3	4	3	4	9
Last Close Price	0.02	0.03	0.05	0.04	0.07	0.15
PS Ratio	-	-	730.98	191.87	-	-
PB Ratio	-0.86	-1.29	-2.50	-2.08	1.20	2.21
EV/Sales Ratio	-	-	910.96	225.59	-	-
Debt / Equity Ratio	-0.73	-0.73	-0.69	-0.45	0.06	0.01
Net Debt / Equity Ratio	-0.70	-0.70	-0.68	-0.44	0.05	-0.02
Net Debt / EBITDA Ratio	-8.01	-8.01	-2.22	-1.75	-0.38	0.08
Net Debt / FCF Ratio	-8.05	-8.05	-4.29	-2.26	-0.79	0.21
Asset Turnover	-	-	0.03	0.01	-	-
Inventory Turnover	-	-	-	0.06	-	-
Quick Ratio	0.03	0.03	0.01	0.01	0.02	0.19
Current Ratio	0.04	0.04	0.03	0.16	0.23	0.25
Return on Equity (ROE)	-	-	-	-426.41%	-29.78%	-37.25%
Return on Assets (ROA)	-163.11%	-163.11%	-169.16%	-23.23%	-13.83%	-19.90%
Return on Capital Employed (ROCE)	8.90%	8.90%	30.80%	73.10%	-31.20%	-40.00%
Earnings Yield	-27.36%	-18.24%	-2.47%	-185.55%	-27.90%	-18.60%
FCF Yield	-	-6.75%	-6.33%	-9.31%	-5.70%	-4.82%
Buyback Yield / Dilution	-0.54%	-0.54%	-	-	-	-18.55%

Updated Oct 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.